Skip to main content
OpenTrials
Completed

NCT Number: NCT05743062

Awe Inducing Elements in Virtual Reality Applications: A Prospective Study of Hospitalized Children

This is an experimental study to evaluate which aspects of virtual reality (VR) software development can be optimized to increase awe in pediatric perioperative patients and their adult caregivers (e.g., parents, guardians)

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Awe

Age range

6 year–99 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Lucile Parkard Children's Hospital

Stanford, California, 94304, United States

About this study

Hospitalized pediatric patients, especially those undergoing anesthesia and surgery, experience anxiety and fear, resulting in lack of cooperation, withdrawal, and aggression. These reactions delay medical care and negatively impact patient experience.

This is an experimental, prospective study to evaluate which aspects of virtual reality (VR) software development can be optimized to increase awe in pediatric perioperative patients and their adult caregivers. The primary center for this study will be Lucile Packard Children's Hospital Stanford (LPCHS) (located within Stanford University, Palo Alto, CA).

After software development, we will evaluate the awe and engagement of pediatric patients after experiencing the novel virtual reality application.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient with age range from 6 to 25
  • Adult or LAR with age range from 18 to 99
  • Able to consent or have parental consent
  • in pre-operative holding and inpatient acute care areas of LCPH
  • English speaking participants

Exclusion criteria

  • People who do not consent
  • Significant Cognitive Impairment
  • History of Severe Motion Sickness
  • Visual Problems
  • currently have nausea
  • history of seizures
  • non-english participants

Treatment and study plan

Virtual reality

Behavioral

Virtual reality intervention will be given 6 times in total and each session will last not more than 60 seconds. Participants will be asked to fill out a survey before the intervention to collect the baseline data, after each session of VR intervention and a final survey at the end of the study.

Control

Other

For case control, participants will service as their self control and no VR intervention will be given at first. Participants will be asked to fill out a survey before the intervention to collect the baseline data.

Primary outcomes

  1. Change in awe levels measured by Global Perceived Awe Survey

    Time frame: Duration of intervention, approximately 20-30 minutes

    Global Perceived Awe Survey contains an 7-point Likert scale . Scores range from 1 (strongly disagree) to 7 (Strongly agree), with higher score indicates strongly agree to the statement.

Secondary outcomes

  1. Change in engagement measured by Game Engagement Questionnaire

    Time frame: Duration of intervention, approximately 20-30 minutes

    Game Engagement Questionnaire contains 19 items . Scores range from 1 (strongly disagree) to 7 (Strongly agree), with higher score indicates strongly agree to the statement.

  2. Change in awe levels measured by Perceived Vastness Survey

    Time frame: Duration of intervention, approximately 20-30 minutes

    Perceived Vastness Survey contains 4 items . Scores range from 1 (strongly disagree) to 7 (Strongly agree), with higher score indicates strongly agree to the statement.

  3. Change in awe levels measured by Perceived Need for Accommodation Survey

    Time frame: Duration of intervention, approximately 20-30 minutes

    Perceived Need for Accommodation Survey contains 3 items . Scores range from 1 (strongly disagree) to 7 (Strongly agree), with higher score indicates strongly agree to the statement.

Sponsors and collaborators

Lead sponsor

Stanford University

Other

Registry information

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Feb 24, 2023
Registry last updated
Jan 31, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.